In the United States, there are a large number of incarcerated individuals, resulting in high numbers of previously incarcerated individuals out on parole-who will be referred to as parolees in this paper-undergoing reentry into society. In 2016, this translated to 2640 per 100 000 adult residents in the United States being under correctional supervision, or roughly 1 in every 38 adults. 1 An aging prison population translates to an older parolee population, which translates to increased incidence of kidney disease, dialysis, and transplant needs, and therefore overall healthcare costs for this population. This is further impacted by a large African American population in prisons and later on parole, some of whom are also disproportionately impacted by renal failure due to a long recognized increased prevalence of end-stage renal disease (ESRD) in African American and Hispanic populations. 2 This paper will discuss the access needs of the parolee (previously incarcerated) population specifically; the larger issue of overall disparities in medical treatment for minority populations, including those individuals currently incarcerated and those no longer on parole, is beyond the scope of a single article. Prisoners have a constitutional right to health care, based on the United States Supreme Court decision in Estelle v. Gamble in 1976, which held that "deliberate indifference to a prison inmate's health